Back to Search Start Over

RON Receptor‐Targeted Antibody‐Drug Conjugate Therapy Ablates Cancer Stem Cells and Induces Long‐term Tumor Regressions in Preclinical Models of Triple‐Negative Breast Cancer (TNBC)

Authors :
Hangping Yao
Ming-Hai Wang
Sreedhar Reddy Suthe
Source :
The FASEB Journal. 33
Publication Year :
2019
Publisher :
Wiley, 2019.

Subjects

Subjects :
Antibody-Drug Conjugate Therapy
Cancer stem cell
business.industry
Genetics
Cancer research
Medicine
Receptor
business
Molecular Biology
Biochemistry
Triple-negative breast cancer
Biotechnology

Details

ISSN :
15306860 and 08926638
Volume :
33
Database :
OpenAIRE
Journal :
The FASEB Journal
Accession number :
edsair.doi...........b483810c31f9286492ae03eb33333e6b

Tools

Authors Abstract Subjects Details